Refine
Year of publication
Document Type
- Article (69)
Language
- English (69)
Has Fulltext
- yes (69)
Is part of the Bibliography
- no (69)
Keywords
- - (35)
- periodontitis (8)
- Alzheimer’s disease (4)
- magnetic resonance imaging (4)
- obesity (4)
- Obesity (3)
- cohort study (3)
- epidemiology (3)
- metabolomics (3)
- Brain-derived neurotrophic factor (2)
- Depression (2)
- Epidemiology (2)
- Iodine (2)
- Thyroid (2)
- Thyroid-stimulating hormone (2)
- Vitamin D (2)
- biomarkers (2)
- cardiorespiratory fitness (2)
- caries (2)
- depression (2)
- metabolic syndrome (2)
- periodontal treatment (2)
- tooth loss (2)
- 3,5-Diiodothyronine (1)
- APOE ε4 (1)
- Abdominal fat (1)
- Aging (1)
- Albuminuria (1)
- Alexithymia (1)
- Alzheimer's disease (1)
- Ankle-brachial index (1)
- BDNF (1)
- Body fat (1)
- Brain health (1)
- CVD biomarker (1)
- Centrality (1)
- Childhood abuse (1)
- Connectivity (1)
- Correlation networks (1)
- Cortex (1)
- Cortical thickness (1)
- Cortisol (1)
- Depressive symptoms (1)
- ECG (1)
- Estimated glomerular filtration rate (1)
- FreeSurfer (1)
- GWA (1)
- General population (1)
- Glucocorticoid receptor (1)
- HLA (1)
- Hand grip strength (1)
- Hippocampus (1)
- Individualization (1)
- Iodine status (1)
- Kidney disease (1)
- Left ventricular geometry and function (1)
- Left ventricular hypertrophy (1)
- Left ventricular mass (1)
- Leptin (1)
- MDD (1)
- MHC (1)
- MRI (1)
- MRI-proton-density-fat-fraction (PDFF) (1)
- Mastication (1)
- Measurement error (1)
- NAFLD (1)
- NAKO (1)
- NMR metabolomics (1)
- NMR spectroscopy (1)
- NR3C1 (1)
- Outcomes research (1)
- PHQ-9 (1)
- Peripheral arterial disease (1)
- Population-based study (1)
- Prediction (1)
- Prevention (1)
- RMSSD (1)
- Resilience (1)
- Risk factors (1)
- Sleep (1)
- Slow wave sleep (1)
- Spermidine (1)
- Sphingosine-1-phosphate (1)
- Staphyloccus aureus (1)
- Study of Health in Pomerania (1)
- TSH (1)
- TSST-1 (1)
- Teeth (1)
- The Study of Health in Pomerania (1)
- Thyroglobulin (1)
- Thyroid function (1)
- Thyroid hormone (1)
- Thyroid imaging (1)
- Thyrotropin (1)
- Tooth loss (1)
- Total testosterone (1)
- Trigonelline (1)
- Urinary iodine excretion (1)
- Urine metabolome (1)
- Variability (1)
- Verbal memory (1)
- Visceral adipose tissue (1)
- Visceral body fat (1)
- abuse (1)
- adult-onset (1)
- affective disorders (1)
- alpha diversity (1)
- amyloid beta (1)
- anthropometry (1)
- anti- (1)
- antibody (1)
- antibody repertoire (1)
- apparently healthy (1)
- area deprivation (1)
- autoimmune (1)
- bacteria (1)
- baseline imbalance (1)
- benzoate metabolism (1)
- biological aging (1)
- biomarker (1)
- bipolar disorder (1)
- blood cell metabolism (1)
- blood count (1)
- body mass index (1)
- body weights and measures (1)
- bone quality (1)
- bone remodelling (1)
- bone turnover marker (1)
- cardiometabolic diseases (1)
- cardiorespiratory exercise capacity (1)
- cardiovascular diseas (1)
- citrulline (1)
- clinical attachment level (1)
- cluster (1)
- cognition (1)
- cohorts (1)
- complete blood count (1)
- continuous outcome (1)
- cortical thickness (1)
- cortisol (1)
- delivery mode (1)
- dementia (1)
- dental flossing (1)
- depresion (1)
- diabetes mellitus (1)
- diagnostic techniques and procedures (1)
- diet (1)
- directed acyclic graphs (1)
- echocardiography (1)
- edentulism (1)
- education (1)
- endothelium (1)
- epidemiologic studies (1)
- estimated bone mineral density (1)
- fT3 (1)
- fT4 (1)
- fat-free mass (1)
- flow‐mediated dilation (1)
- general population-based cohort (1)
- glucose homeostasis (1)
- glucose metabolism (1)
- heart rate variability (HRV) (1)
- hepatic steatosis (1)
- hippocampal volume (1)
- homoarginine (1)
- host-pathogen-interaction (1)
- immunoproteomics (1)
- income (1)
- individual participant data (1)
- individualized medicine (1)
- inflammation (1)
- inter-dental cleaning (1)
- interdental brushing (1)
- iron surrogates (1)
- large cohort data (1)
- late-onset (1)
- lipid profile (1)
- lipoprotein profile (1)
- lipoprotein profiling (1)
- liver fat content (1)
- longitudinal cohort study (1)
- machine learning (1)
- macrovascular disease (1)
- measurement error (1)
- mediatation (1)
- mediation (1)
- memory (1)
- metabolic phenotypes (1)
- metabolism (1)
- metabolome (1)
- metabotypes (1)
- miRNA (1)
- microbiome (1)
- neglect (1)
- nitric oxide (1)
- non-randomized studies (1)
- number of missing teeth (1)
- offspring (1)
- oral contraceptives (1)
- orofacial pain (1)
- peak oxygen uptake (1)
- perinatal (1)
- periodontal diseases (1)
- personalized medicine (1)
- phenotyping (1)
- population-based (1)
- population-based imaging (1)
- population-based studies (1)
- population‐based study (1)
- powered tooth brush (1)
- powered toothbrush (1)
- pre-symptomatic Alzheimer’s disease marker (1)
- prediabetes (1)
- prediction modelling (1)
- probing depth (1)
- prognostic factors (1)
- prospective cohort study (1)
- proton pump inhibitor (1)
- public health (1)
- radiomics (1)
- registry-based analysis (1)
- risk factor progression (1)
- risk factors (1)
- rs56149945 (1)
- sedentarism (1)
- self-report (1)
- serum markers (1)
- sex (1)
- sex differences (1)
- sex-specific (1)
- signal transduction (1)
- sleep disorders (1)
- sleep macro-architecture (1)
- slow-wave sleep (1)
- spermidine (1)
- spleen volume (1)
- superantigen (1)
- third molar (1)
- thyroid (1)
- tooth extraction (1)
- toxic shock syndrome (1)
- trace amine-associated receptor 1 (1)
- trauma (1)
- variants (1)
- weight regulation (1)
- white matter hyperintensities (1)
- whole-body magnetic resonance imaging (1)
- whole‐body imaging (1)
Institute
- Institut für Community Medicine (18)
- Klinik für Psychiatrie und Psychotherapie (13)
- Kliniken und Polikliniken für Innere Medizin (13)
- Institut für Klinische Chemie und Laboratoriumsmedizin (7)
- Zentrum für Zahn-, Mund- und Kieferheilkunde (7)
- Institut für Biometrie und Medizinische Informatik (2)
- Institut für Diagnostische Radiologie (2)
- Institut für Immunologie u. Transfusionsmedizin - Abteilung Immunologie (2)
- Klinik und Poliklinik für Augenheilkunde (2)
- Klinik und Poliklinik für Mund-, Kiefer- und Gesichtschirurgie/Plastische Operationen (2)
Publisher
- Wiley (12)
- S. Karger AG (10)
- Frontiers Media S.A. (9)
- MDPI (9)
- Nature Publishing Group (5)
- Springer Nature (5)
- Public Library of Science (PLoS) (4)
- SAGE Publications (4)
- BioMed Central (BMC) (1)
- BioScientifica (1)
Background
We investigated the association between low cardiorespiratory fitness and liver fat content (LFC) in the general population.
Materials and Methods
We evaluated data from 2151 adults (51.1% women) from two population-based cohorts of the Study of Health in Pomerania (SHIP-2 and SHIP-TREND-0). We analysed the cross-sectional associations of peak oxygen uptake (VO2peak) with LFC, assessed by magnetic resonance imaging proton density fat fraction, as well as serum gamma-glutamyltransferase (GGT) and aminotransferase concentrations by multivariable regression models.
Results
We observed significant inverse associations of VO2peak with LFC and serum GGT, but not with serum aminotransferase levels. Specifically, a 1 L/min lower VO2peak was associated with a 1.09% (95% confidence interval [CI]: 0.45-1.73; P = .002) higher LFC and a 0.18 μkatal/L (95% CI: 0.09-0.26; P < .001) higher GGT levels. The adjusted odds ratio (OR) for the risk of prevalent hepatic steatosis (HS) by a 1 L/min decrease in VO2peak was 1.61 (95% CI: 1.22-2.13; P = .001). Compared to subjects with high VO2peak, obese and overweight individuals with low VO2peak had 1.78% (95% CI: 0.32-3.25; P = .017) and 0.94% (95% CI: 0.15-1.74; P = .021) higher mean LFC, respectively. Compared to those with high VO2peak, low VO2peak was independently associated with a higher risk of prevalent HS in the obese (adjusted-OR 2.29, 95% CI=1.48-3.56; P < .001) and overweight (adjusted OR 1.57, 95% CI=1.16-2.14; P = .04) groups.
Conclusions
Lower VO2peak was significantly associated with greater LFC and higher serum GGT levels in a population-based cohort of adult individuals. Our results suggest that low VO2peak might be a risk factor for HS.
Deteriorations in slow wave sleep (SWS) have been linked to brain aging and Alzheimer’s disease (AD), possibly due to its key role in clearance of amyloid-beta and tau (Aß/tau), two pathogenic hallmarks of AD. Spermidine administration has been shown to improve sleep quality in animal models. So far, the association between spermidine levels in humans and parameters of SWS physiology are unknown but may be valuable for therapeutic strategies. Data from 216 participants (age range 50–81 years) of the population-based Study of Health in Pomerania TREND were included in our analysis. We investigated associations between spermidine plasma levels, key parameters of sleep macroarchitecture and microarchitecture that were previously associated with AD pathology, and brain health measured via a marker of structural brain atrophy (AD score). Higher spermidine levels were significantly associated with lower coupling between slow oscillations and spindle activity. No association was evident for SWS, slow oscillatory, and spindle activity throughout non-rapid eye movement sleep. Furthermore, elevated spermidine blood levels were significantly associated with a higher AD score, while sleep markers revealed no association with AD score. The association between higher spermidine levels and brain health was not mediated by coupling between slow oscillations and spindle activity. We report that higher spermidine blood levels are associated not only with deteriorated brain health but also with less advantageous markers of sleep quality in older adults. Future studies need to evaluate whether sleep, spermidine, and Aß/tau deposition are interrelated and whether sleep may play a mediating role.
Introduction
Supplementation with spermidine may support healthy aging, but elevated spermidine tissue levels were shown to be an indicator of Alzheimer's disease (AD).
Methods
Data from 659 participants (age range: 21–81 years) of the population-based Study of Health in Pomerania TREND were included. We investigated the association between spermidine plasma levels and markers of brain aging (hippocampal volume, AD score, global cortical thickness [CT], and white matter hyperintensities [WMH]).
Results
Higher spermidine levels were significantly associated with lower hippocampal volume (ß = −0.076; 95% confidence interval [CI]: −0.13 to −0.02; q = 0.026), higher AD score (ß = 0.118; 95% CI: 0.05 to 0.19; q = 0.006), lower global CT (ß = −0.104; 95% CI: −0.17 to −0.04; q = 0.014), but not WMH volume. Sensitivity analysis revealed no substantial changes after excluding participants with cancer, depression, or hemolysis.
Discussion
Elevated spermidine plasma levels are associated with advanced brain aging and might serve as potential early biomarker for AD and vascular brain pathology.
Background: Abdominal obesity is a major driver for adverse medical conditions. While an interaction between adipose tissue and thyroid function is thought to exist, to our knowledge, no study has examined the effect of thyroid-stimulating hormone (TSH) on visceral adipose tissue (VAT) in a population-based context. Objective: We determined an association between serum TSH levels and VAT. Methods: A sample of 1,021 female and 956 male adults aged 20-79 years was drawn from registry offices in the cross-sectional, population-based Study of Health in Pomerania Trend (SHIP Trend) in Northeast Germany from 2008 to 2012. Our main exposure was serum TSH levels. Our main outcome was VAT measured using magnetic resonance imaging. The possibly mediating role of leptin on the TSH-VAT association was also assessed. Results: A total of 1,719 participants (87.9%) had serum TSH levels within the reference range. The mean volume of VAT was 5.33 liters for men and 2.83 liters for women. No association between TSH and VAT (β = 0.06, 95% CI: -0.02, 0.14) was observed, and there were no differences detected between sexes. VAT was strongly associated with leptin with a greater effect in women than in men. Leptin was strongly associated with TSH. Conclusions: No association between TSH and VAT was observed. Other biomarkers such as leptin may play a role in the relationship between thyroid function and metabolic risk.
Life-threatening toxic shock syndrome is often caused by the superantigen toxic shock syndrome toxin-1 (TSST-1) produced by Staphylococcus aureus. A well-known risk factor is the lack of neutralizing antibodies. To identify determinants of the anti-TSST-1 antibody response, we examined 976 participants of the German population-based epidemiological Study of Health in Pomerania (SHIP-TREND-0). We measured anti-TSST-1 antibody levels, analyzed the colonization with TSST-1-encoding S. aureus strains, and performed a genome-wide association analysis of genetic risk factors. TSST-1-specific serum IgG levels varied over a range of 4.2 logs and were elevated by a factor of 12.3 upon nasal colonization with TSST-1-encoding S. aureus. Moreover, the anti-TSST-1 antibody levels were strongly associated with HLA class II gene loci. HLA-DRB1*03:01 and HLA-DQB1*02:01 were positively, and HLA-DRB1*01:01 as well as HLA-DQB1*05:01 negatively associated with the anti-TSST-1 antibody levels. Thus, both toxin exposure and HLA alleles affect the human antibody response to TSST-1.
The relationship between Alzheimer's-related brain atrophy patterns and sleep macro-architecture
(2022)
Introduction
Sleep is increasingly recognized as a major risk factor for neurodegenerative disorders such as Alzheimer's disease (AD).
Methods
Using an magnetic resonance imaging (MRI)–based AD score based on clinical data from the Alzheimer's Disease Neuroimaging Initiative 1 (ADNI1) case-control cohort, we investigated the associations between polysomnography-based sleep macro-architecture and AD-related brain atrophy patterns in 712 pre-symptomatic, healthy subjects from the population-based Study of Health in Pomerania.
Results
We identified a robust inverse association between slow-wave sleep and the AD marker (estimate: −0.019; 95% confidence interval: −0.03 to −0.0076; false discovery rate [FDR] = 0.0041), as well as with gray matter (GM) thicknesses in typical individual cortical AD-signature regions. No effects were identified regarding rapid eye movement or non–rapid eye movement (NREM) stage 2 sleep, and NREM stage 1 was positively associated with GM thickness, mainly in the prefrontal cortical regions.
Discussion
There is a cross-sectional relationship between AD-related neurodegenerative patterns and the proportion of sleep spent in slow-wave sleep.
Background: Iodine deficiency disorders (IDD) represent a global health threat to individuals and societies. IDD prevention programmes have been introduced in many parts of the world. However, challenges remain, particularly in Europe due to fragmentation and diversity of approaches that are not harmonized. Objectives: This review is dedicated to the public-health impact of IDD prevention programmes. It sums up experiences collected by the EUthyroid consortium so far and provides information on stakeholders that should be involved in actions directed to improve the impact of IDD prevention. Methods: A joint European database for combining registry-based outcome and monitoring data as well as tools for harmonizing study methods were established. Methods for analyzing thyroglobulin from a dried blood spot are available for assessing the iodine status in the general population and at-risk groups. Mother-child cohorts are used for in-depth analysis of the potential impact of mild-to-moderate iodine deficiency on the neurocognitive development of the offspring. A decision-analytic model has been developed to evaluate the long-term effectiveness and cost effectiveness of IDD prevention programmes. Results: EUthyroid has produced tools and infrastructure to improve the quality of IDD monitoring and follows a dissemination strategy targeting policymakers and the general public. There are tight connections to major stakeholders in the field of IDD monitoring and prevention. Conclusions: EUthyroid has taken steps towards achieving a euthyroid Europe. Our challenge is to inspire a greater sense of urgency in both policymakers and the wider public to address this remediable deficit caused by IDD.
Childhood abuse was inconsistently related to whole-brain cortical thickness in former studies. However, both childhood abuse and cortical thickness have been associated with depressive symptoms. We hypothesised that childhood abuse moderates the association between depressive symptoms and cortical thickness. In 1551 individuals of the general population, associations between whole-brain cortical thickness and the interaction of childhood abuse (emotional, physical, and sexual) and depressive symptoms were analysed using an ANCOVA. Linear regression analyses were used to estimate the same effect on the cortical thickness of 34 separate regions (Desikan-Killiany-atlas). A significant interaction effect of childhood abuse and depressive symptoms was observed for whole-brain cortical thickness (F(2, 1534) = 5.28, p = 0.007). A thinner cortex was associated with depressive symptoms in abused (t value = 2.78, p = 0.025) but not in non-abused participants (t value = − 1.50, p = 0.224). Focussing on non-depressed participants, a thicker whole-brain cortex was found in abused compared to non-abused participants (t value = − 2.79, p = 0.025). Similar interaction effects were observed in 12 out of 34 cortical regions. Our results suggest that childhood abuse is associated with reduced cortical thickness in subjects with depressive symptoms. In abused subjects without depressive symptoms, larger cortical thickness might act compensatory and thus reflect resilience against depressive symptoms.
The hypothalamus–pituitary–adrenal axis is the main physiological stress response system and regulating the release of cortisol. The two corticoid receptors encoded by the genes NR3C1 and NR3C2 are the main players in regulating the physiological response to cortisol. This biological system has been linked to neurocognitive processes and memory, yet the mechanisms remain largely unclear. In two independent general population studies (SHIP, total sample size > 5500), we aim to diseantangle the effects of genetic variation, gene expression and cortisol on verbal memory and memory associated brain volume. Especially for NR3C1 results exhibited a consistent pattern of direct an interactive effects. All three biological layers, genetic variation (rs56149945), gene expression for NR3C1 and cortisol levels, were directly associated with verbal memory. Interactions between these components showed significant effects on verbal memory as well as hippocampal volume. For NR3C2 such a complex association pattern could not be observed. Our analyses revealed that different components of the stress response system are acting together on different aspects of cognition. Complex phenotypes, such as cognition and memory function are regulated by a complex interplay between different genetic and epigenetic features. We promote the glucocorticoid receptor NR3C1 as a main target to focus in the context of verbal memory and provided a mechanistic concept of the interaction between various biological layers spanning NR3C1 function and its effects on memory. Especially the NR3C1 transcript seemed to be a key element in this complex system.
Background: Alexithymia is a personality trait characterized by difficulties in identifying and describing emotions and associated with various psychiatric disorders. Neuroimaging studies found evidence for morphological and functional brain alterations in alexithymic subjects. However, the neurobiological mechanisms underlying alexithymia remain incompletely understood. Methods: We study the association of alexithymia with cortical correlation networks in a large community-dwelling sample of the Study of Health in Pomerania. Our analysis includes data of n = 2,199 individuals (49.4% females, age = 52.1 ± 13.6 years) which were divided into a low and high alexithymic group by a median split of the Toronto Alexithymia Scale. Cortical correlation networks were constructed based on the mean thicknesses of 68 regions, and differences in centralities were investigated. Results: We found a significantly increased centrality of the right paracentral lobule in the high alexithymia network after correction for multiple testing. Several other regions with motoric and sensory functions showed altered centrality on a nominally significant level. Conclusions: Finding increased centrality of the paracentral lobule, a brain area with sensory as well as motoric features and involvement in bowel and bladder voiding, may contribute to explain the association of alexithymia with functional somatic disorders and chronic pain syndromes.